gild
| 1:30PM 5/26/2009
Biotechnology company United Therapeutics Corp. (UTHR) announced today it has received a Food and Drug Administration approval for Adcirca, once-a-day 40 mg tablets for the treatment of pulmonary arterial hypertension (PAH).
PAH is a progressive, life-threatening disease in which the pressure in a...
| 4:00PM 4/17/2009
When we hear of pharmaceutical companies' ventures it's usually either a straight merger & acquisition or a collaboration on a drug or two in their pipelines to share costs and, of course, potential profits. But Pfizer Inc. (PFE) and GlaxoSmithKline (GSK) have come up with a new one.
Rather...